International Stem Cell Corporation Company

International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called parthenogenesis which uses unfertilized eggs, and promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection.
They are focused on using these stem cells to treat diseases of the eye, the nervous system and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells or tissue.
Technology: Regenerative medicine - cell therapy
Industry: Regenerative Medicine
Headquarters: Carlsbad
Founded Date: 2001
Employees Number: Undisclosed
Funding Status: IPO

Visit Website
Register and Claim Ownership